Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - Angiotensin-Converting-Enzyme (ACE) Inhibitor Therapy

NCT02432885 is registered in ClinicalTrials.gov with InCor Heart Institute as lead sponsor.

NCT NCT02432885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02432885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - Angiotensin-Converting-Enzyme (ACE) Inhibitor Therapy
Lead sponsor
InCor Heart Institute
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
June 30, 2013
Enrollment
76 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

muscular dystrophies, myocardial fibrosis